Teva has chosen INFOTEHNA’s XEVPRM solution eMPDExpert!

Teva, the largest generic drug manufacturer in the world, will use INFOTEHNA eMPDExpert^TM to submit its entire European product portfolio information to EMA by regulatory deadline, July 2nd.

In addition to its strive to efficiency in both operations and total cost for all vendor solutions, main evaluation criteria used to evaluate SW solutions on the market were flexibility of connecting to various data sources, system features, required effort from the business and project duration.

INFOTEHNA eMPDExpert^TM, the newest member of INFOTEHNA myPharmaExpert^TM Suite, was the solution that received top ranking after weeks of detailed evaluation, including shaping very clear implementation path by our Life sciences professional services team.

Joint teams are already engaged in building the solution that will take and win the challenge of meeting XEVPRM regulatory requirements for probably the biggest product portfolio on the market.